What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? – Considerations on pre-analytical aspects by the IFCC workgroup cfDNA

Autor: Danesi, R., Lo, Y.M.D., Oellerich, M., Beck, J., Galbiati, S., Re, M. Del, Lianidou, E., Neumaier, M., van Schaik, R.H.N.
Zdroj: In Clinica Chimica Acta September 2021 520:168-171
Databáze: ScienceDirect
Externí odkaz: